Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-100244

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Isaac E. Ciechanover
Officer — Chief Executive Officer · Director
Period of report
Feb 16, 2016
Accepted (ET)
Feb 18, 2016 · 8:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Feb 16, 2016M5,908$0.00A217,321D
Common StockF2holding———379,211ISee footnote
Common StockF3holding———450,824ISee footnote
Common StockF4holding———180,000ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F6,F7—Feb 16, 2016M5,908D——Common Stock5,90845,292D

Explanation of responses